--2024/Q4-- / 7.644B--
Oct 30, 20242024/Q38.012B / 8.007B--
Jul 31, 20242024/Q27.884B / 7.493B--
May 1, 20242024/Q17.363B / 7.060B--
--2023/Q48.052B / 7.621B--
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 33.930
- +0.230+0.68%
Trading Nov 22 10:55 ET
69.23BMarket Cap22.21P/E (TTM)
33.955High33.770Low1.40MVolume33.890Open33.700Pre Close47.45MTurnover0.07%Turnover Ratio11.24P/E (Static)2.04BShares44.84752wk High3.93P/B67.02BFloat Cap32.82552wk Low1.60Dividend TTM1.98BShs Float44.847Historical High4.72%Div YieldTTM0.55%Amplitude6.373Historical Low33.847Avg Price1Lot Size
GlaxoSmithKline Key Stats
GlaxoSmithKline Q3 2024 Earnings Date
Currency：GBPOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 8.01B | 8.01B | +5.14M |
| Beat Est. | -1.72% | -1.66% | +0.06% |
| EPS | 0.12 | -0.03 | -0.14 |
| Miss Est. | -84.82% | -103.93% | -124.05% |
Analyst Rating
Nov 12, 2024
GlaxoSmithKline Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: GBP
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
GlaxoSmithKline Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
